CLINICAL ROLE -
Use of PD-1/PD-L1 and VEGF Inhibition Combination Is Expanding
The relatively new combination of PD-1/PD-L1 inhibitors with VEGF inhibitors represents a promising option for patients with various malignancies.
Read More